These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7635420)

  • 1. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4.
    Miller LC; Kaplan MM
    Am J Gastroenterol; 1992 Apr; 87(4):465-70. PubMed ID: 1553933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.
    Miettinen TA; Färkkilä M; Vuoristo M; Karvonen AL; Leino R; Lehtola J; Friman C; Seppälä K; Tuominen J
    Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
    Kaplan MM; Cheng S; Price LL; Bonis PA
    Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methotrexate in the therapy of primary biliary cirrhosis].
    Weber P; Scheurlen M; Wiedmann KH
    Dtsch Med Wochenschr; 1991 Sep; 116(36):1347-52. PubMed ID: 1884674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response to alkaline phosphatase and other immunogens in patients with primary biliary cirrhosis.
    Harding G; McKenna R; Minuk G
    Hepatogastroenterology; 2001; 48(37):66-70. PubMed ID: 11269001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFSF9 expression in primary biliary cirrhosis and its clinical significance.
    Xia R; Tang Y; Huang Y; Yao D; Zhou Y; Chen B; Chen Y; Chen S; Deng A; Zhong R
    Cytokine; 2010 Jun; 50(3):311-6. PubMed ID: 20303781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.
    Zifroni A; Schaffner F
    Hepatology; 1991 Dec; 14(6):990-3. PubMed ID: 1959887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cirrhosis (PBC): is effective therapy now at hand?
    Kaplan MM; Knox TA; Arora S
    Trans Assoc Am Physicians; 1988; 101():193-202. PubMed ID: 3269678
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.
    Kaplan MM; Schmid C; Provenzale D; Sharma A; Dickstein G; McKusick A
    Gastroenterology; 1999 Nov; 117(5):1173-80. PubMed ID: 10535881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic trials in primary biliary cirrhosis.
    Sherlock S
    QJM; 1994 Nov; 87(11):701-3. PubMed ID: 7820545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.